John R. Wingard mainly focuses on Internal medicine, Transplantation, Surgery, Gastroenterology and Hematopoietic stem cell transplantation. His Internal medicine research includes themes of Aspergillosis and Mycosis. His study in Transplantation is interdisciplinary in nature, drawing from both Gerontology, Regimen, Myeloid leukemia, Immunology and Intensive care medicine.
His Intensive care medicine research includes elements of Hematopoietic cell, Cancer, Clinical trial, MEDLINE and Neutropenia. His research investigates the connection between Surgery and topics such as Epidemiology that intersect with issues in Aspergillus. His studies deal with areas such as Amphotericin B, Nephrotoxicity, Multicenter trial, Randomized controlled trial and Graft-versus-host disease as well as Gastroenterology.
His primary scientific interests are in Internal medicine, Transplantation, Surgery, Immunology and Hematopoietic stem cell transplantation. His work deals with themes such as Gastroenterology and Oncology, which intersect with Internal medicine. His study looks at the relationship between Transplantation and topics such as Intensive care medicine, which overlap with MEDLINE, Aspergillosis and Antifungal.
His work is dedicated to discovering how Surgery, Bone marrow are connected with Haematopoiesis and other disciplines. He interconnects Progenitor cell, CD34 and Stem cell in the investigation of issues within Immunology. His studies in Hematopoietic stem cell transplantation integrate themes in fields like Cancer and Cohort.
His primary areas of study are Transplantation, Internal medicine, Immunology, Hematopoietic stem cell transplantation and Oncology. His Transplantation research integrates issues from Hematopoietic cell, Leukemia, Disease and Intensive care medicine. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Surgery.
His Surgery course of study focuses on Bone marrow and Myeloid leukemia, Chemotherapy and Biopsy. He combines subjects such as Microbiome, Hematopoietic stem cell and Pneumonia with his study of Immunology. John R. Wingard has researched Clinical trial in several fields, including Cancer, Randomized controlled trial, Myelodysplastic syndromes and Lenalidomide.
His primary areas of study are Transplantation, Hematopoietic stem cell transplantation, Internal medicine, Immunology and Graft-versus-host disease. The Transplantation study combines topics in areas such as Hematopoietic cell, Leukemia, Retrospective cohort study and Family medicine. His work carried out in the field of Hematopoietic stem cell transplantation brings together such families of science as Ex vivo, Hematopoietic stem cell, Quality of life and Oncolytic virus.
His research in Internal medicine intersects with topics in Gastroenterology, Surgery and Oncology. His Clinical trial research is multidisciplinary, relying on both Cancer, Maintenance therapy and Intensive care medicine. As a part of the same scientific study, he usually deals with the Intensive care medicine, concentrating on Aspergillosis and frequently concerns with MEDLINE and Cunninghamella bertholletiae.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett.
The New England Journal of Medicine (2002)
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Thomas J. Walsh;Elias J. Anaissie;David W. Denning;Raoul Herbrecht.
Clinical Infectious Diseases (2008)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld;Eric J. Bow;Kent A. Sepkowitz;Michael J. Boeckh.
Clinical Infectious Diseases (2011)
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.
Marcie Tomblyn;Tom Chiller;Hermann Einsele;Ronald Gress.
Biology of Blood and Marrow Transplantation (2009)
Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective
M. Tomblyn;T. Chiller;H. Einsele;R. Gress.
Bone Marrow Transplantation (2009)
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America
Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman.
Clinical Infectious Diseases (2016)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiennis;Kieren A. Marr;Benjamin J. Park;Barbara D. Alexander.
Clinical Infectious Diseases (2010)
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
Thomas J. Walsh;Peter Pappas;Drew J. Winston;Hillard M. Lazarus.
The New England Journal of Medicine (2002)
Increase in Candida krusei Infection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole
John R. Wingard;William G. Merz;Michael G. Rinaldi;Thomas R. Johnson.
The New England Journal of Medicine (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Center for International Blood and Marrow Transplant Research
Case Western Reserve University
Johns Hopkins University
Fred Hutchinson Cancer Research Center
Vanderbilt University Medical Center
Weill Cornell Medicine
University of Minnesota
Johns Hopkins University School of Medicine
The University of Texas Health Science Center at San Antonio
University of Strasbourg
Carnegie Mellon University
University of Maryland, College Park
Leiden University
Microsoft (United States)
University at Buffalo, State University of New York
National University of Singapore
Nagoya University
University of Cologne
National and Kapodistrian University of Athens
University of Bremen
Portland State University
University of Nottingham
University of Innsbruck
Simon Fraser University
RMIT University
Wake Forest University